Clinical Trials Browser

Interventional × B-Cell Activating Factor × Clear all

NCT00024934 2016-09-22

B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

Phase 1 Completed

Immunologic Deficiency Syndromes, Neoplasms, IgA Deficiency

NCT00006113 2014-05-22

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Terminated

Melanoma